Journal of the International Aids Society 2018

2 papers

Top Research Directions

The 6 research directions with Journal of the International Aids Society 2018 papers, ranked by paper count, next to 2017. Share is the fraction of the edition’s papers in the direction.

#Direction20182017Share 2018Share 20172017 rank
1Bridging the Economic Viability Assessment Gap1050.0%0.0%—
2Comparative Intervention Designs for Causal Inference1050.0%0.0%—
3Demographic Normalization in Epidemiological Analysis1050.0%0.0%—
4Multi State Markov Models for Long Term Clinical Projections1050.0%0.0%—
5The Incremental Cost-Effectiveness Ratio for Healthcare Resource Allocation1050.0%0.0%—
6The Viral Suppression Lag in Treatment as Prevention1050.0%0.0%—

Download all directions as CSV

About this data

Papers. Journal of the International Aids Society 2018 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2017 use shares, since the edition went from 2 to 2 papers.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions. Cite as: Lacuna, “Journal of the International Aids Society 2018”, https://lacuna.tiptreesystems.com/venue/journal-of-the-international-aids-society/2018.

Top Authors

AuthorPapers
Claudio Jose Struchiner1
Rodolphe Thiébaut1

Impactful Papers

Papers from Journal of the International Aids Society 2018 that shaped research clusters.

Foundational

Influential

Papers

Title
The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil
The impact of population dynamics on the population <scp>HIV</scp> care cascade: results from the <scp>ANRS</scp> 12249 Treatment as Prevention trial in rural KwaZulu‐Natal (South Africa)